Global Vunakizumab Market Growth 2026-2032
The global Vunakizumab market size is predicted to grow from US$ 24.46 million in 2025 to US$ 181 million in 2032; it is expected to grow at a CAGR of 9.1% from 2026 to 2032.
Vunakizumab is a humanized anti?IL?17A monoclonal antibody independently developed by Hengrui Medicine. It can specifically bind to Interleukin?17A (IL?17A), block its interaction with receptors, inhibit inflammatory signaling pathways, and reduce inflammation in the skin, joints and other tissues. It is mainly used for the treatment of psoriasis, ankylosing spondylitis, psoriatic arthritis and other autoimmune diseases, characterized by high affinity, long half?life, long dosing interval and good safety.In 2025, global vunakizumab production reached approximately 1.2 million vials.
Vunakizumab is a Class 1 domestic innovative drug independently developed by Hengrui Medicine and one of the first anti-IL-17A monoclonal antibodies approved in China. Since its launch, it has rapidly become an important participant in the therapeutic market for autoimmune diseases. With the advantages of high affinity, low immunogenicity, rapid onset and convenient administration, the drug has broken the long-term monopoly of imported IL-17A inhibitors and provided a domestic alternative for patients with psoriasis, ankylosing spondylitis and other diseases. Driven by three core factors, namely medical insurance coverage, expanded indications and optimized pricing, its market penetration has been continuously improved, making it a core growth product in the field of domestic autoimmunity. In terms of competitive landscape, vunakizumab and selicilizumab from Chuangxiang Jintai constitute the first echelon of domestic IL-17A inhibitors, forming a competition pattern of 'import-dominated, domestic catching-up' with imported products from Novartis, Eli Lilly and other companies. In the future, relying on Hengrui's commercialization capacity, medical insurance volume expansion effect and potential indication expansion (such as psoriatic arthritis and rheumatoid arthritis), vunakizumab is expected to further expand its market share and promote domestic substitution and price penetration in the domestic autoimmune disease treatment market.
LP Information, Inc. (LPI) ' newest research report, the ?Vunakizumab Industry Forecast? looks at past sales and reviews total world Vunakizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Vunakizumab sales for 2026 through 2032. With Vunakizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vunakizumab industry.
This Insight Report provides a comprehensive analysis of the global Vunakizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vunakizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Vunakizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vunakizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vunakizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Vunakizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vunakizumab market?
What factors are driving Vunakizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vunakizumab market opportunities vary by end market size?
How does Vunakizumab break out by Type, by Application?
Vunakizumab is a humanized anti?IL?17A monoclonal antibody independently developed by Hengrui Medicine. It can specifically bind to Interleukin?17A (IL?17A), block its interaction with receptors, inhibit inflammatory signaling pathways, and reduce inflammation in the skin, joints and other tissues. It is mainly used for the treatment of psoriasis, ankylosing spondylitis, psoriatic arthritis and other autoimmune diseases, characterized by high affinity, long half?life, long dosing interval and good safety.In 2025, global vunakizumab production reached approximately 1.2 million vials.
Vunakizumab is a Class 1 domestic innovative drug independently developed by Hengrui Medicine and one of the first anti-IL-17A monoclonal antibodies approved in China. Since its launch, it has rapidly become an important participant in the therapeutic market for autoimmune diseases. With the advantages of high affinity, low immunogenicity, rapid onset and convenient administration, the drug has broken the long-term monopoly of imported IL-17A inhibitors and provided a domestic alternative for patients with psoriasis, ankylosing spondylitis and other diseases. Driven by three core factors, namely medical insurance coverage, expanded indications and optimized pricing, its market penetration has been continuously improved, making it a core growth product in the field of domestic autoimmunity. In terms of competitive landscape, vunakizumab and selicilizumab from Chuangxiang Jintai constitute the first echelon of domestic IL-17A inhibitors, forming a competition pattern of 'import-dominated, domestic catching-up' with imported products from Novartis, Eli Lilly and other companies. In the future, relying on Hengrui's commercialization capacity, medical insurance volume expansion effect and potential indication expansion (such as psoriatic arthritis and rheumatoid arthritis), vunakizumab is expected to further expand its market share and promote domestic substitution and price penetration in the domestic autoimmune disease treatment market.
LP Information, Inc. (LPI) ' newest research report, the ?Vunakizumab Industry Forecast? looks at past sales and reviews total world Vunakizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Vunakizumab sales for 2026 through 2032. With Vunakizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vunakizumab industry.
This Insight Report provides a comprehensive analysis of the global Vunakizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vunakizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Vunakizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vunakizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vunakizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Vunakizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 120 mg / 1 ml
- 240 mg / 2 ml
- Innovator
- Generic
- Monoclonal Antibody
- Polyclonal Antibody
- Hospital
- Retail
- Online
- Moderate to Severe Plaque Psoriasis
- Ankylosing Spondylitis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Suzhou Shengdiya Biopharmaceutical
- Jiangsu Hengrui Medicine
What is the 10-year outlook for the global Vunakizumab market?
What factors are driving Vunakizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vunakizumab market opportunities vary by end market size?
How does Vunakizumab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vunakizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Vunakizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Vunakizumab by Country/Region, 2021, 2025 & 2032
2.2 Vunakizumab Segment by Type
2.2.1 120 mg / 1 ml
2.2.2 240 mg / 2 ml
2.2.3 Vunakizumab Sales by Type
2.2.3.1 Global Vunakizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Vunakizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Vunakizumab Sale Price by Type (2021-2026)
2.3 Vunakizumab Segment by Production Technology
2.3.1 Innovator
2.3.2 Generic
2.3.3 Vunakizumab Sales by Production Technology
2.3.3.1 Global Vunakizumab Sales Market Share by Production Technology (2021-2026)
2.3.3.2 Global Vunakizumab Revenue and Market Share by Production Technology (2021-2026)
2.3.3.3 Global Vunakizumab Sale Price by Production Technology (2021-2026)
2.4 Vunakizumab Segment by Antibody Type
2.4.1 Monoclonal Antibody
2.4.2 Polyclonal Antibody
2.4.3 Vunakizumab Sales by Antibody Type
2.4.3.1 Global Vunakizumab Sales Market Share by Antibody Type (2021-2026)
2.4.3.2 Global Vunakizumab Revenue and Market Share by Antibody Type (2021-2026)
2.4.3.3 Global Vunakizumab Sale Price by Antibody Type (2021-2026)
2.5 Vunakizumab Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Vunakizumab Sales by Sales Channels
2.5.4.1 Global Vunakizumab Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Vunakizumab Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Vunakizumab Sale Price by Sales Channels (2021-2026)
2.6 Vunakizumab Segment by Application
2.6.1 Moderate to Severe Plaque Psoriasis
2.6.2 Ankylosing Spondylitis
2.6.3 Others
2.6.4 Vunakizumab Sales by Application
2.6.4.1 Global Vunakizumab Sale Market Share by Application (2021-2026)
2.6.4.2 Global Vunakizumab Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Vunakizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Vunakizumab Breakdown Data by Company
3.1.1 Global Vunakizumab Annual Sales by Company (2021-2026)
3.1.2 Global Vunakizumab Sales Market Share by Company (2021-2026)
3.2 Global Vunakizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Vunakizumab Revenue by Company (2021-2026)
3.2.2 Global Vunakizumab Revenue Market Share by Company (2021-2026)
3.3 Global Vunakizumab Sale Price by Company
3.4 Key Manufacturers Vunakizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vunakizumab Product Location Distribution
3.4.2 Players Vunakizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VUNAKIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Vunakizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Vunakizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Vunakizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vunakizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Vunakizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Vunakizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vunakizumab Sales Growth
4.4 APAC Vunakizumab Sales Growth
4.5 Europe Vunakizumab Sales Growth
4.6 Middle East & Africa Vunakizumab Sales Growth
5 AMERICAS
5.1 Americas Vunakizumab Sales by Country
5.1.1 Americas Vunakizumab Sales by Country (2021-2026)
5.1.2 Americas Vunakizumab Revenue by Country (2021-2026)
5.2 Americas Vunakizumab Sales by Type (2021-2026)
5.3 Americas Vunakizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vunakizumab Sales by Region
6.1.1 APAC Vunakizumab Sales by Region (2021-2026)
6.1.2 APAC Vunakizumab Revenue by Region (2021-2026)
6.2 APAC Vunakizumab Sales by Type (2021-2026)
6.3 APAC Vunakizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vunakizumab by Country
7.1.1 Europe Vunakizumab Sales by Country (2021-2026)
7.1.2 Europe Vunakizumab Revenue by Country (2021-2026)
7.2 Europe Vunakizumab Sales by Type (2021-2026)
7.3 Europe Vunakizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vunakizumab by Country
8.1.1 Middle East & Africa Vunakizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Vunakizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Vunakizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Vunakizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vunakizumab
10.3 Manufacturing Process Analysis of Vunakizumab
10.4 Industry Chain Structure of Vunakizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vunakizumab Distributors
11.3 Vunakizumab Customer
12 WORLD FORECAST REVIEW FOR VUNAKIZUMAB BY GEOGRAPHIC REGION
12.1 Global Vunakizumab Market Size Forecast by Region
12.1.1 Global Vunakizumab Forecast by Region (2027-2032)
12.1.2 Global Vunakizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vunakizumab Forecast by Type (2027-2032)
12.7 Global Vunakizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Suzhou Shengdiya Biopharmaceutical
13.1.1 Suzhou Shengdiya Biopharmaceutical Company Information
13.1.2 Suzhou Shengdiya Biopharmaceutical Vunakizumab Product Portfolios and Specifications
13.1.3 Suzhou Shengdiya Biopharmaceutical Vunakizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Suzhou Shengdiya Biopharmaceutical Main Business Overview
13.1.5 Suzhou Shengdiya Biopharmaceutical Latest Developments
13.2 Jiangsu Hengrui Medicine
13.2.1 Jiangsu Hengrui Medicine Company Information
13.2.2 Jiangsu Hengrui Medicine Vunakizumab Product Portfolios and Specifications
13.2.3 Jiangsu Hengrui Medicine Vunakizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangsu Hengrui Medicine Main Business Overview
13.2.5 Jiangsu Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vunakizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Vunakizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Vunakizumab by Country/Region, 2021, 2025 & 2032
2.2 Vunakizumab Segment by Type
2.2.1 120 mg / 1 ml
2.2.2 240 mg / 2 ml
2.2.3 Vunakizumab Sales by Type
2.2.3.1 Global Vunakizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Vunakizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Vunakizumab Sale Price by Type (2021-2026)
2.3 Vunakizumab Segment by Production Technology
2.3.1 Innovator
2.3.2 Generic
2.3.3 Vunakizumab Sales by Production Technology
2.3.3.1 Global Vunakizumab Sales Market Share by Production Technology (2021-2026)
2.3.3.2 Global Vunakizumab Revenue and Market Share by Production Technology (2021-2026)
2.3.3.3 Global Vunakizumab Sale Price by Production Technology (2021-2026)
2.4 Vunakizumab Segment by Antibody Type
2.4.1 Monoclonal Antibody
2.4.2 Polyclonal Antibody
2.4.3 Vunakizumab Sales by Antibody Type
2.4.3.1 Global Vunakizumab Sales Market Share by Antibody Type (2021-2026)
2.4.3.2 Global Vunakizumab Revenue and Market Share by Antibody Type (2021-2026)
2.4.3.3 Global Vunakizumab Sale Price by Antibody Type (2021-2026)
2.5 Vunakizumab Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Vunakizumab Sales by Sales Channels
2.5.4.1 Global Vunakizumab Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global Vunakizumab Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global Vunakizumab Sale Price by Sales Channels (2021-2026)
2.6 Vunakizumab Segment by Application
2.6.1 Moderate to Severe Plaque Psoriasis
2.6.2 Ankylosing Spondylitis
2.6.3 Others
2.6.4 Vunakizumab Sales by Application
2.6.4.1 Global Vunakizumab Sale Market Share by Application (2021-2026)
2.6.4.2 Global Vunakizumab Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Vunakizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Vunakizumab Breakdown Data by Company
3.1.1 Global Vunakizumab Annual Sales by Company (2021-2026)
3.1.2 Global Vunakizumab Sales Market Share by Company (2021-2026)
3.2 Global Vunakizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Vunakizumab Revenue by Company (2021-2026)
3.2.2 Global Vunakizumab Revenue Market Share by Company (2021-2026)
3.3 Global Vunakizumab Sale Price by Company
3.4 Key Manufacturers Vunakizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vunakizumab Product Location Distribution
3.4.2 Players Vunakizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VUNAKIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Vunakizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Vunakizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Vunakizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vunakizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Vunakizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Vunakizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vunakizumab Sales Growth
4.4 APAC Vunakizumab Sales Growth
4.5 Europe Vunakizumab Sales Growth
4.6 Middle East & Africa Vunakizumab Sales Growth
5 AMERICAS
5.1 Americas Vunakizumab Sales by Country
5.1.1 Americas Vunakizumab Sales by Country (2021-2026)
5.1.2 Americas Vunakizumab Revenue by Country (2021-2026)
5.2 Americas Vunakizumab Sales by Type (2021-2026)
5.3 Americas Vunakizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vunakizumab Sales by Region
6.1.1 APAC Vunakizumab Sales by Region (2021-2026)
6.1.2 APAC Vunakizumab Revenue by Region (2021-2026)
6.2 APAC Vunakizumab Sales by Type (2021-2026)
6.3 APAC Vunakizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vunakizumab by Country
7.1.1 Europe Vunakizumab Sales by Country (2021-2026)
7.1.2 Europe Vunakizumab Revenue by Country (2021-2026)
7.2 Europe Vunakizumab Sales by Type (2021-2026)
7.3 Europe Vunakizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vunakizumab by Country
8.1.1 Middle East & Africa Vunakizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Vunakizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Vunakizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Vunakizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vunakizumab
10.3 Manufacturing Process Analysis of Vunakizumab
10.4 Industry Chain Structure of Vunakizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vunakizumab Distributors
11.3 Vunakizumab Customer
12 WORLD FORECAST REVIEW FOR VUNAKIZUMAB BY GEOGRAPHIC REGION
12.1 Global Vunakizumab Market Size Forecast by Region
12.1.1 Global Vunakizumab Forecast by Region (2027-2032)
12.1.2 Global Vunakizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vunakizumab Forecast by Type (2027-2032)
12.7 Global Vunakizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Suzhou Shengdiya Biopharmaceutical
13.1.1 Suzhou Shengdiya Biopharmaceutical Company Information
13.1.2 Suzhou Shengdiya Biopharmaceutical Vunakizumab Product Portfolios and Specifications
13.1.3 Suzhou Shengdiya Biopharmaceutical Vunakizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Suzhou Shengdiya Biopharmaceutical Main Business Overview
13.1.5 Suzhou Shengdiya Biopharmaceutical Latest Developments
13.2 Jiangsu Hengrui Medicine
13.2.1 Jiangsu Hengrui Medicine Company Information
13.2.2 Jiangsu Hengrui Medicine Vunakizumab Product Portfolios and Specifications
13.2.3 Jiangsu Hengrui Medicine Vunakizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangsu Hengrui Medicine Main Business Overview
13.2.5 Jiangsu Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vunakizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vunakizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 120 mg / 1 ml
Table 4. Major Players of 240 mg / 2 ml
Table 5. Global Vunakizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Vunakizumab Sales Market Share by Type (2021-2026)
Table 7. Global Vunakizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Vunakizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Vunakizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Innovator
Table 11. Major Players of Generic
Table 12. Global Vunakizumab Sales by Production Technology (2021-2026) & (Units)
Table 13. Global Vunakizumab Sales Market Share by Production Technology (2021-2026)
Table 14. Global Vunakizumab Revenue by Production Technology (2021-2026) & ($ million)
Table 15. Global Vunakizumab Revenue Market Share by Production Technology (2021-2026)
Table 16. Global Vunakizumab Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 17. Major Players of Monoclonal Antibody
Table 18. Major Players of Polyclonal Antibody
Table 19. Global Vunakizumab Sales by Antibody Type (2021-2026) & (Units)
Table 20. Global Vunakizumab Sales Market Share by Antibody Type (2021-2026)
Table 21. Global Vunakizumab Revenue by Antibody Type (2021-2026) & ($ million)
Table 22. Global Vunakizumab Revenue Market Share by Antibody Type (2021-2026)
Table 23. Global Vunakizumab Sale Price by Antibody Type (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Vunakizumab Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Vunakizumab Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Vunakizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Vunakizumab Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Vunakizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Vunakizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Vunakizumab Sale Market Share by Application (2021-2026)
Table 34. Global Vunakizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Vunakizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Vunakizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Vunakizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Vunakizumab Sales Market Share by Company (2021-2026)
Table 39. Global Vunakizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Vunakizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Vunakizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Vunakizumab Producing Area Distribution and Sales Area
Table 43. Players Vunakizumab Products Offered
Table 44. Vunakizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Vunakizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Vunakizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Vunakizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Vunakizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Vunakizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Vunakizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Vunakizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Vunakizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Vunakizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Vunakizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Vunakizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Vunakizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Vunakizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Vunakizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Vunakizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Vunakizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Vunakizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Vunakizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Vunakizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Vunakizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Vunakizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Vunakizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Vunakizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Vunakizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Vunakizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Vunakizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Vunakizumab
Table 74. Key Market Challenges & Risks of Vunakizumab
Table 75. Key Industry Trends of Vunakizumab
Table 76. Vunakizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Vunakizumab Distributors List
Table 79. Vunakizumab Customer List
Table 80. Global Vunakizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Vunakizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Vunakizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Vunakizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Vunakizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Vunakizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Vunakizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Vunakizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Vunakizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Vunakizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Vunakizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Vunakizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Vunakizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Vunakizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Suzhou Shengdiya Biopharmaceutical Basic Information, Vunakizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Suzhou Shengdiya Biopharmaceutical Vunakizumab Product Portfolios and Specifications
Table 96. Suzhou Shengdiya Biopharmaceutical Vunakizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Suzhou Shengdiya Biopharmaceutical Main Business
Table 98. Suzhou Shengdiya Biopharmaceutical Latest Developments
Table 99. Jiangsu Hengrui Medicine Basic Information, Vunakizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangsu Hengrui Medicine Vunakizumab Product Portfolios and Specifications
Table 101. Jiangsu Hengrui Medicine Vunakizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Jiangsu Hengrui Medicine Main Business
Table 103. Jiangsu Hengrui Medicine Latest Developments
Table 1. Vunakizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vunakizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 120 mg / 1 ml
Table 4. Major Players of 240 mg / 2 ml
Table 5. Global Vunakizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Vunakizumab Sales Market Share by Type (2021-2026)
Table 7. Global Vunakizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Vunakizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Vunakizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Innovator
Table 11. Major Players of Generic
Table 12. Global Vunakizumab Sales by Production Technology (2021-2026) & (Units)
Table 13. Global Vunakizumab Sales Market Share by Production Technology (2021-2026)
Table 14. Global Vunakizumab Revenue by Production Technology (2021-2026) & ($ million)
Table 15. Global Vunakizumab Revenue Market Share by Production Technology (2021-2026)
Table 16. Global Vunakizumab Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 17. Major Players of Monoclonal Antibody
Table 18. Major Players of Polyclonal Antibody
Table 19. Global Vunakizumab Sales by Antibody Type (2021-2026) & (Units)
Table 20. Global Vunakizumab Sales Market Share by Antibody Type (2021-2026)
Table 21. Global Vunakizumab Revenue by Antibody Type (2021-2026) & ($ million)
Table 22. Global Vunakizumab Revenue Market Share by Antibody Type (2021-2026)
Table 23. Global Vunakizumab Sale Price by Antibody Type (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Vunakizumab Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global Vunakizumab Sales Market Share by Sales Channels (2021-2026)
Table 29. Global Vunakizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global Vunakizumab Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global Vunakizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global Vunakizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Vunakizumab Sale Market Share by Application (2021-2026)
Table 34. Global Vunakizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Vunakizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Vunakizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Vunakizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Vunakizumab Sales Market Share by Company (2021-2026)
Table 39. Global Vunakizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Vunakizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Vunakizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Vunakizumab Producing Area Distribution and Sales Area
Table 43. Players Vunakizumab Products Offered
Table 44. Vunakizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Vunakizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Vunakizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Vunakizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Vunakizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Vunakizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Vunakizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Vunakizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Vunakizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Vunakizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Vunakizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Vunakizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Vunakizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Vunakizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Vunakizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Vunakizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Vunakizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Vunakizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Vunakizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Vunakizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Vunakizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Vunakizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Vunakizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Vunakizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Vunakizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Vunakizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Vunakizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Vunakizumab
Table 74. Key Market Challenges & Risks of Vunakizumab
Table 75. Key Industry Trends of Vunakizumab
Table 76. Vunakizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Vunakizumab Distributors List
Table 79. Vunakizumab Customer List
Table 80. Global Vunakizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Vunakizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Vunakizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Vunakizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Vunakizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Vunakizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Vunakizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Vunakizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Vunakizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Vunakizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Vunakizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Vunakizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Vunakizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Vunakizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Suzhou Shengdiya Biopharmaceutical Basic Information, Vunakizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Suzhou Shengdiya Biopharmaceutical Vunakizumab Product Portfolios and Specifications
Table 96. Suzhou Shengdiya Biopharmaceutical Vunakizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Suzhou Shengdiya Biopharmaceutical Main Business
Table 98. Suzhou Shengdiya Biopharmaceutical Latest Developments
Table 99. Jiangsu Hengrui Medicine Basic Information, Vunakizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangsu Hengrui Medicine Vunakizumab Product Portfolios and Specifications
Table 101. Jiangsu Hengrui Medicine Vunakizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Jiangsu Hengrui Medicine Main Business
Table 103. Jiangsu Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vunakizumab
Figure 2. Vunakizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vunakizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Vunakizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vunakizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vunakizumab Sales Market Share by Country/Region (2025)
Figure 10. Vunakizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 120 mg / 1 ml
Figure 12. Product Picture of 240 mg / 2 ml
Figure 13. Global Vunakizumab Sales Market Share by Type in 2026
Figure 14. Global Vunakizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Innovator
Figure 16. Product Picture of Generic
Figure 17. Global Vunakizumab Sales Market Share by Production Technology in 2026
Figure 18. Global Vunakizumab Revenue Market Share by Production Technology (2021-2026)
Figure 19. Product Picture of Monoclonal Antibody
Figure 20. Product Picture of Polyclonal Antibody
Figure 21. Global Vunakizumab Sales Market Share by Antibody Type in 2026
Figure 22. Global Vunakizumab Revenue Market Share by Antibody Type (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Vunakizumab Sales Market Share by Sales Channels in 2026
Figure 27. Global Vunakizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Vunakizumab Consumed in Moderate to Severe Plaque Psoriasis
Figure 29. Global Vunakizumab Market: Moderate to Severe Plaque Psoriasis (2021-2026) & (Units)
Figure 30. Vunakizumab Consumed in Ankylosing Spondylitis
Figure 31. Global Vunakizumab Market: Ankylosing Spondylitis (2021-2026) & (Units)
Figure 32. Vunakizumab Consumed in Others
Figure 33. Global Vunakizumab Market: Others (2021-2026) & (Units)
Figure 34. Global Vunakizumab Sale Market Share by Application (2025)
Figure 35. Global Vunakizumab Revenue Market Share by Application in 2025
Figure 36. Vunakizumab Sales by Company in 2025 (Units)
Figure 37. Global Vunakizumab Sales Market Share by Company in 2025
Figure 38. Vunakizumab Revenue by Company in 2025 ($ millions)
Figure 39. Global Vunakizumab Revenue Market Share by Company in 2025
Figure 40. Global Vunakizumab Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Vunakizumab Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Vunakizumab Sales 2021-2026 (Units)
Figure 43. Americas Vunakizumab Revenue 2021-2026 ($ millions)
Figure 44. APAC Vunakizumab Sales 2021-2026 (Units)
Figure 45. APAC Vunakizumab Revenue 2021-2026 ($ millions)
Figure 46. Europe Vunakizumab Sales 2021-2026 (Units)
Figure 47. Europe Vunakizumab Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Vunakizumab Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Vunakizumab Revenue 2021-2026 ($ millions)
Figure 50. Americas Vunakizumab Sales Market Share by Country in 2025
Figure 51. Americas Vunakizumab Revenue Market Share by Country (2021-2026)
Figure 52. Americas Vunakizumab Sales Market Share by Type (2021-2026)
Figure 53. Americas Vunakizumab Sales Market Share by Application (2021-2026)
Figure 54. United States Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Vunakizumab Sales Market Share by Region in 2025
Figure 59. APAC Vunakizumab Revenue Market Share by Region (2021-2026)
Figure 60. APAC Vunakizumab Sales Market Share by Type (2021-2026)
Figure 61. APAC Vunakizumab Sales Market Share by Application (2021-2026)
Figure 62. China Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. India Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Vunakizumab Sales Market Share by Country in 2025
Figure 70. Europe Vunakizumab Revenue Market Share by Country (2021-2026)
Figure 71. Europe Vunakizumab Sales Market Share by Type (2021-2026)
Figure 72. Europe Vunakizumab Sales Market Share by Application (2021-2026)
Figure 73. Germany Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 74. France Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Vunakizumab Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Vunakizumab Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Vunakizumab Sales Market Share by Application (2021-2026)
Figure 81. Egypt Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Vunakizumab in 2026
Figure 87. Manufacturing Process Analysis of Vunakizumab
Figure 88. Industry Chain Structure of Vunakizumab
Figure 89. Channels of Distribution
Figure 90. Global Vunakizumab Sales Market Forecast by Region (2027-2032)
Figure 91. Global Vunakizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Vunakizumab Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Vunakizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Vunakizumab Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Vunakizumab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Vunakizumab
Figure 2. Vunakizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vunakizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Vunakizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vunakizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vunakizumab Sales Market Share by Country/Region (2025)
Figure 10. Vunakizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 120 mg / 1 ml
Figure 12. Product Picture of 240 mg / 2 ml
Figure 13. Global Vunakizumab Sales Market Share by Type in 2026
Figure 14. Global Vunakizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Innovator
Figure 16. Product Picture of Generic
Figure 17. Global Vunakizumab Sales Market Share by Production Technology in 2026
Figure 18. Global Vunakizumab Revenue Market Share by Production Technology (2021-2026)
Figure 19. Product Picture of Monoclonal Antibody
Figure 20. Product Picture of Polyclonal Antibody
Figure 21. Global Vunakizumab Sales Market Share by Antibody Type in 2026
Figure 22. Global Vunakizumab Revenue Market Share by Antibody Type (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Vunakizumab Sales Market Share by Sales Channels in 2026
Figure 27. Global Vunakizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 28. Vunakizumab Consumed in Moderate to Severe Plaque Psoriasis
Figure 29. Global Vunakizumab Market: Moderate to Severe Plaque Psoriasis (2021-2026) & (Units)
Figure 30. Vunakizumab Consumed in Ankylosing Spondylitis
Figure 31. Global Vunakizumab Market: Ankylosing Spondylitis (2021-2026) & (Units)
Figure 32. Vunakizumab Consumed in Others
Figure 33. Global Vunakizumab Market: Others (2021-2026) & (Units)
Figure 34. Global Vunakizumab Sale Market Share by Application (2025)
Figure 35. Global Vunakizumab Revenue Market Share by Application in 2025
Figure 36. Vunakizumab Sales by Company in 2025 (Units)
Figure 37. Global Vunakizumab Sales Market Share by Company in 2025
Figure 38. Vunakizumab Revenue by Company in 2025 ($ millions)
Figure 39. Global Vunakizumab Revenue Market Share by Company in 2025
Figure 40. Global Vunakizumab Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Vunakizumab Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Vunakizumab Sales 2021-2026 (Units)
Figure 43. Americas Vunakizumab Revenue 2021-2026 ($ millions)
Figure 44. APAC Vunakizumab Sales 2021-2026 (Units)
Figure 45. APAC Vunakizumab Revenue 2021-2026 ($ millions)
Figure 46. Europe Vunakizumab Sales 2021-2026 (Units)
Figure 47. Europe Vunakizumab Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Vunakizumab Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Vunakizumab Revenue 2021-2026 ($ millions)
Figure 50. Americas Vunakizumab Sales Market Share by Country in 2025
Figure 51. Americas Vunakizumab Revenue Market Share by Country (2021-2026)
Figure 52. Americas Vunakizumab Sales Market Share by Type (2021-2026)
Figure 53. Americas Vunakizumab Sales Market Share by Application (2021-2026)
Figure 54. United States Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Vunakizumab Sales Market Share by Region in 2025
Figure 59. APAC Vunakizumab Revenue Market Share by Region (2021-2026)
Figure 60. APAC Vunakizumab Sales Market Share by Type (2021-2026)
Figure 61. APAC Vunakizumab Sales Market Share by Application (2021-2026)
Figure 62. China Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. India Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Vunakizumab Sales Market Share by Country in 2025
Figure 70. Europe Vunakizumab Revenue Market Share by Country (2021-2026)
Figure 71. Europe Vunakizumab Sales Market Share by Type (2021-2026)
Figure 72. Europe Vunakizumab Sales Market Share by Application (2021-2026)
Figure 73. Germany Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 74. France Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Vunakizumab Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Vunakizumab Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Vunakizumab Sales Market Share by Application (2021-2026)
Figure 81. Egypt Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Vunakizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Vunakizumab in 2026
Figure 87. Manufacturing Process Analysis of Vunakizumab
Figure 88. Industry Chain Structure of Vunakizumab
Figure 89. Channels of Distribution
Figure 90. Global Vunakizumab Sales Market Forecast by Region (2027-2032)
Figure 91. Global Vunakizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Vunakizumab Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Vunakizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Vunakizumab Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Vunakizumab Revenue Market Share Forecast by Application (2027-2032)
